Pemvidutide

Pemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonist

N/A Amino Acids · MW: N/A

Ask AI About This

Amino Acids

N/A

Molecular Weight

N/A

Half-life

Approximately 1 week

Research Score

4.4

Studies

Storage

Store lyophilized at -20°C, reconstituted at 2-8°C

What is Pemvidutide?

Pemvidutide is an investigational long-acting GLP-1/glucagon dual agonist designed to drive weight loss while preserving or improving metabolic rate. It has also been studied for metabolic dysfunction-associated steatohepatitis and obesity.

Key Benefits & Mechanisms

appetite suppression

body-weight reduction

improved liver-fat markers

better glycemic control

Research Summary

Clinical studies have reported dose-dependent weight loss and favorable effects on liver fat and transaminases. It remains investigational and is not approved for obesity treatment.

Related Peptides

Oxyntomodulin

Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide

Oxyntomodulin is a naturally occurring proglucagon-derived peptide that activates GLP-1 and glucagon pathways. It is a key research tool for appetite suppression and energy balance studies in obesity.

Weight Management

Cotadutide

MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist

Cotadutide is a synthetic oxyntomodulin analogue designed to engage both GLP-1 and glucagon receptors. It was developed to improve weight loss and metabolic markers in obesity and type 2 diabetes research.

Weight Management

Mazdutide

IBI362, long-acting GLP-1 receptor and glucagon receptor dual agonist

Mazdutide is a long-acting oxyntomodulin-inspired dual agonist being developed for obesity and metabolic disease. It is designed to drive clinically meaningful weight loss while improving glucose and lipid parameters.

Weight Management

Dulaglutide

Recombinant GLP-1 receptor agonist Fc fusion protein

Dulaglutide is a long-acting GLP-1 receptor agonist used primarily in type 2 diabetes. It consistently produces modest weight loss and is widely studied as a benchmark incretin mimetic.

Weight Management